Muszkiewicz Anna, Britton Oliver J, Gemmell Philip, Passini Elisa, Sánchez Carlos, Zhou Xin, Carusi Annamaria, Quinn T Alexander, Burrage Kevin, Bueno-Orovio Alfonso, Rodriguez Blanca
Department of Computer Science, University of Oxford, Parks Road, Oxford OX1 3QD, United Kingdom.
Clyde Biosciences Ltd, West Medical Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom.
Prog Biophys Mol Biol. 2016 Jan;120(1-3):115-27. doi: 10.1016/j.pbiomolbio.2015.12.002. Epub 2015 Dec 14.
Physiological variability manifests itself via differences in physiological function between individuals of the same species, and has crucial implications in disease progression and treatment. Despite its importance, physiological variability has traditionally been ignored in experimental and computational investigations due to averaging over samples from multiple individuals. Recently, modelling frameworks have been devised for studying mechanisms underlying physiological variability in cardiac electrophysiology and pro-arrhythmic risk under a variety of conditions and for several animal species as well as human. One such methodology exploits populations of cardiac cell models constrained with experimental data, or experimentally-calibrated populations of models. In this review, we outline the considerations behind constructing an experimentally-calibrated population of models and review the studies that have employed this approach to investigate variability in cardiac electrophysiology in physiological and pathological conditions, as well as under drug action. We also describe the methodology and compare it with alternative approaches for studying variability in cardiac electrophysiology, including cell-specific modelling approaches, sensitivity-analysis based methods, and populations-of-models frameworks that do not consider the experimental calibration step. We conclude with an outlook for the future, predicting the potential of new methodologies for patient-specific modelling extending beyond the single virtual physiological human paradigm.
生理变异性通过同一物种个体间生理功能的差异表现出来,并且在疾病进展和治疗中具有关键意义。尽管其很重要,但由于对多个个体的样本进行平均,生理变异性在传统的实验和计算研究中一直被忽视。最近,已经设计出建模框架,用于研究各种条件下以及多种动物物种和人类的心脏电生理学中生理变异性的潜在机制以及致心律失常风险。一种这样的方法利用受实验数据约束的心脏细胞模型群体,或经过实验校准的模型群体。在这篇综述中,我们概述了构建经过实验校准的模型群体背后的考量因素,并回顾了那些采用这种方法来研究生理和病理条件下以及药物作用下心脏电生理学变异性的研究。我们还描述了该方法,并将其与研究心脏电生理学变异性的其他方法进行比较,包括细胞特异性建模方法、基于敏感性分析的方法以及不考虑实验校准步骤的模型群体框架。我们以对未来的展望作为结论,预测新方法在超越单一虚拟生理人类范式的患者特异性建模方面的潜力。